USANA Health Sciences (USNA) Misses Q3 EPS by 14c; Lowers FY Outlook
Get Alerts USNA Hot Sheet
Price: $14.22 -3.4%
EPS Growth %: +386.7%
Financial Fact:
Other, net: -24K
Today's EPS Names:
FNLC, LSBK, OVLY, More
EPS Growth %: +386.7%
Financial Fact:
Other, net: -24K
Today's EPS Names:
FNLC, LSBK, OVLY, More
Join SI Premium – FREE
USANA Health Sciences (NYSE: USNA) reported Q3 EPS of $0.78, $0.14 worse than the analyst estimate of $0.92. Revenue for the quarter came in at $233 million versus the consensus estimate of $245.95 million.
GUIDANCE:
USANA Health Sciences sees FY2022 EPS of $3.15-$3.40, versus the consensus of $3.90. USANA Health Sciences sees FY2022 revenue of $0.955-0.975 billion, versus the consensus of $1.03 billion.
For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Integra LifeSciences (IART) Tops Q3 EPS by 3c; offers guidance
- Southern Missouri Bancorp (SMBC) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share